Can a common ADHD drug help Parkinson's patients stop freezing in their tracks?
NCT ID NCT07316296
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether atomoxetine, a medication that affects noradrenaline, can reduce freezing of gait in people with Parkinson's disease. About 60 participants will take either atomoxetine or a placebo and perform walking tests, MRI scans, and questionnaires. The goal is to see if the drug can help them walk more smoothly and improve their quality of life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FREEZING OF GAIT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Radboudumc
RECRUITINGNijmegen, Gelderland, 6525 GA, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can brain signals predict freezing episodes in Parkinson's?
- Can a new pill slow Parkinson's symptoms?
- Dancing away Parkinson's symptoms: tango therapy put to the test
- Gentle bowing, calmer mind: music therapy put to the test for Parkinson's anxiety
- Can a voice therapy program help turkish speakers with Parkinson's speak louder and clearer?
- Can a gene therapy rewire brain cells to ease Parkinson's?